Zoetis Inc. (ZTS) Debt Components
- 2026-06-30: Commercial PaperUSD $0.00; Short-term DebtUSD (m); Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD $9.05B.
- 2026-03-31: Commercial PaperUSD $0.00; Short-term DebtUSD (m); Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD $9.04B.
- 2025-12-31: Commercial PaperUSD $0.00; Short-term DebtUSD (m); Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD $9.04B.
- 2025-12-31: Commercial PaperUSD (m); Short-term DebtUSD (m); Long-term Debt, Current MaturitiesUSD $0.00; Long-term Debt, Excluding Current MaturitiesUSD (m).
Zoetis Inc. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Commercial Paper USD | Short-term Debt USD | Long-term Debt, Current Maturities USD | Long-term Debt, Excluding Current Maturities USD | Long-Term Debt, Maturity, Year One USD | Long-Term Debt, Maturity, Year Two USD | Long-Term Debt, Maturity, Year Three USD | Long-Term Debt, Maturity, Year Four USD | Long-Term Debt, Maturity, Year Five USD | Long-Term Debt, Maturity, Remainder of Fiscal Year USD | Line of Credit Facility, Maximum Borrowing Capacity USD | Long-term Debt, Gross USD | Debt Instrument, Unamortized Discount (Premium), Net USD | Debt, Current USD | Long-term Line of Credit USD | Long-Term Debt, Maturity, after Year Five USD | Short-term Debt, Weighted Average Interest Rate, at Point in Time pure | Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | (m) | (m) | $9.05B | $750.00M | $1.35B | $2.00B | $750.00M | (m) | $0.00 | $46.00M | $9.15B | $-85.00M | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $0.00 | (m) | (m) | $9.04B | $750.00M | $1.35B | $2.00B | $750.00M | (m) | $0.00 | $47.00M | $9.15B | $-89.00M | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $0.00 | (m) | (m) | $9.04B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $9.15B | $-93.00M | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | (m) | $0.00 | (m) | $0.00 | $750.00M | $1.35B | $2.00B | $750.00M | (m) | $51.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $0.00 | (m) | $0.00 | $7.07B | $0.00 | $750.00M | $1.35B | $0.00 | (m) | $0.00 | $60.00M | $7.15B | $-64.00M | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $0.00 | (m) | $1.35B | $5.23B | $0.00 | $750.00M | $500.00M | $0.00 | (m) | $1.35B | $53.00M | $6.65B | $-51.00M | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $0.00 | (m) | $1.35B | $5.23B | $0.00 | $750.00M | $500.00M | $0.00 | (m) | $1.35B | $51.00M | $6.65B | $-52.00M | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $0.00 | (m) | $1.35B | $5.22B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $6.65B | $54.00M | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | $0.00 | (m) | (m) | $1.35B | $0.00 | $750.00M | $500.00M | $0.00 | (m) | $50.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $0.00 | $0.00 | (m) | $6.57B | $1.35B | $0.00 | $750.00M | $500.00M | (m) | $0.00 | $56.00M | $6.65B | $-56.00M | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $0.00 | $0.00 | (m) | $6.56B | $1.35B | $0.00 | $750.00M | $500.00M | (m) | $0.00 | $55.00M | $6.65B | $-57.00M | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $0.00 | $24.00M | (m) | $6.56B | $1.35B | $0.00 | $750.00M | $500.00M | (m) | $0.00 | $60.00M | $6.65B | $-59.00M | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | $3.00M | $0.00 | $6.56B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $6.65B | $60.00M | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | (m) | (m) | (m) | $0.00 | $1.35B | $0.00 | $750.00M | $500.00M | (m) | $56.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $0.00 | $2.00M | $0.00 | $6.55B | $0.00 | $1.35B | $0.00 | $750.00M | (m) | $0.00 | $50.00M | $6.65B | $-62.00M | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $0.00 | $2.00M | $0.00 | $6.55B | $0.00 | $1.35B | $0.00 | $750.00M | (m) | $0.00 | $52.00M | $6.65B | $-63.00M | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | $0.00 | $3.00M | $0.00 | $6.56B | $0.00 | $1.35B | $0.00 | $750.00M | (m) | $0.00 | $51.00M | $6.65B | $-65.00M | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | $2.00M | $1.35B | $6.55B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $8.00B | $66.00M | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | (m) | (m) | (m) | $1.35B | $0.00 | $1.35B | $0.00 | $750.00M | (m) | $51.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | $0.00 | $3.00M | $1.35B | $5.21B | $1.35B | $0.00 | $750.00M | $0.00 | (m) | $0.00 | $50.00M | $6.65B | $-56.00M | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | $0.00 | $2.00M | $1.35B | $5.22B | $1.35B | $0.00 | $750.00M | $0.00 | (m) | $0.00 | $51.00M | $6.65B | $-58.00M | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | $0.00 | (m) | $1.35B | $5.23B | $1.35B | $0.00 | $750.00M | $0.00 | (m) | $0.00 | $64.00M | $6.65B | $-59.00M | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | $0.00 | $0.00 | $6.59B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $6.65B | $-60.00M | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | (m) | (m) | (m) | $0.00 | $1.35B | $0.00 | $750.00M | $0.00 | (m) | $63.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | $0.00 | $0.00 | $0.00 | $6.59B | $0.00 | $1.35B | $0.00 | $750.00M | (m) | $0.00 | $71.00M | $6.65B | $-62.00M | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | $0.00 | $4.00M | $600.00M | $6.59B | $0.00 | $1.35B | $0.00 | $750.00M | (m) | $600.00M | $79.00M | $7.25B | $-63.00M | (m) | $4.00M | (m) | (m) | (m) |
| 2021-03-31 | $0.00 | $4.00M | $600.00M | $6.59B | (m) | $0.00 | $1.35B | $0.00 | $750.00M | $600.00M | $80.00M | $7.25B | $-65.00M | (m) | $4.00M | $4.55B | (m) | (m) |
| 2020-12-31 | $0.00 | $4.00M | $600.00M | $6.59B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $7.25B | $-66.00M | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $4.00M | (m) | (m) | (m) |
| 2020-12-31 | (m) | (m) | (m) | (m) | (m) | $600.00M | $0.00 | $1.35B | $0.00 | (m) | $79.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | $0.00 | $1.00M | $1.10B | $6.59B | (m) | $600.00M | $0.00 | $1.35B | $0.00 | $500.00M | $77.00M | $7.75B | $-68.00M | (m) | $0.00 | $5.30B | (m) | (m) |
| 2020-06-30 | $1.50M | $1.00M | $500.00M | $7.19B | (m) | $600.00M | $0.00 | $1.35B | $0.00 | $500.00M | $75.00M | $7.75B | $-70.00M | (m) | $0.00 | $5.30B | (m) | (m) |
| 2020-03-31 | $0.00 | (m) | $500.00M | $5.96B | (m) | $600.00M | $0.00 | $1.35B | $0.00 | $500.00M | $75.00M | $6.50B | $-49.00M | $500.00M | $0.00 | $4.05B | (m) | (m) |
| 2019-12-31 | $0.00 | $0.00 | $500.00M | $5.95B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $6.50B | $-51.00M | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) |
| 2019-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $500.00M | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | (m) | (m) | (m) | (m) | $500.00M | $600.00M | $0.00 | $1.35B | (m) | $76.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-09-30 | $0.00 | $0.00 | (m) | $6.45B | (m) | $500.00M | $600.00M | $0.00 | $1.35B | (m) | $76.00M | $6.50B | $-53.00M | (m) | $0.00 | $4.05B | (m) | (m) |
| 2019-06-30 | $0.00 | $0.00 | (m) | $6.45B | (m) | $500.00M | $600.00M | $0.00 | $1.35B | (m) | $73.00M | $6.50B | $-54.00M | (m) | $0.00 | $4.05B | (m) | (m) |
| 2019-03-31 | $0.00 | $0.00 | (m) | $6.44B | (m) | $500.00M | $600.00M | $0.00 | $1.35B | (m) | $73.00M | $6.50B | $-56.00M | (m) | $0.00 | $4.05B | (m) | (m) |
| 2018-12-31 | $0.00 | $9.00M | $0.00 | $6.44B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $6.50B | $-57.00M | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) |
| 2018-12-31 | (m) | (m) | (m) | (m) | (m) | $0.00 | $500.00M | $600.00M | $0.00 | (m) | $77.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-09-30 | $0.00 | (m) | (m) | $6.44B | (m) | $0.00 | $500.00M | $600.00M | $0.00 | (m) | $75.00M | $6.50B | $-59.00M | (m) | $0.00 | $5.40B | (m) | (m) |
| 2018-06-30 | $0.00 | (m) | (m) | $4.96B | (m) | $0.00 | $500.00M | $0.00 | $0.00 | (m) | $61.00M | $5.00B | $-45.00M | (m) | $0.00 | $4.50B | (m) | (m) |
| 2018-03-31 | $0.00 | (m) | (m) | $4.95B | (m) | $0.00 | $500.00M | $0.00 | $0.00 | (m) | $71.00M | $5.00B | $-46.00M | (m) | $0.00 | $4.50B | (m) | (m) |
| 2017-12-31 | $0.00 | (m) | (m) | $4.95B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $5.00B | $-47.00M | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) |
| 2017-12-31 | (m) | (m) | $0.00 | (m) | (m) | $0.00 | $0.00 | $500.00M | $0.00 | (m) | $75.00M | (m) | (m) | (m) | (m) | $4.50B | (m) | (m) |
| 2017-10-01 | (m) | (m) | $750.00M | $4.95B | (m) | $750.00M | $0.00 | $500.00M | $0.00 | (m) | $77.00M | $5.75B | $-48.00M | (m) | $0.00 | $4.50B | (m) | (m) |
| 2017-07-02 | (m) | $100.00M | $750.00M | $3.72B | (m) | $750.00M | $0.00 | $500.00M | $0.00 | (m) | $75.00M | $4.50B | $-31.00M | (m) | $0.00 | $3.25B | (m) | (m) |
| 2017-04-02 | $0.00 | (m) | $750.00M | $3.72B | (m) | $750.00M | $0.00 | $500.00M | $0.00 | (m) | $75.00M | $4.50B | $-32.00M | (m) | $0.00 | $3.25B | (m) | (m) |
| 2016-12-31 | $0.00 | (m) | $0.00 | $4.47B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $4.50B | $-32.00M | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) |
| 2016-12-31 | (m) | (m) | (m) | (m) | (m) | $0.00 | $750.00M | $0.00 | $500.00M | (m) | $75.00M | (m) | (m) | $0.00 | (m) | $3.25B | 5.20% | (m) |
| 2016-10-02 | $0.00 | (m) | $0.00 | $4.47B | (m) | $0.00 | $750.00M | $0.00 | $500.00M | (m) | $81.00M | $4.50B | $-34.00M | $0.00 | $0.00 | $3.25B | (m) | (m) |
| 2016-07-03 | $0.00 | (m) | $0.00 | $4.46B | (m) | $0.00 | $750.00M | $0.00 | $500.00M | (m) | $91.00M | $4.50B | $-35.00M | $4.00M | $0.00 | (m) | 5.40% | (m) |
| 2016-04-03 | $0.00 | (m) | $0.00 | $4.46B | (m) | $0.00 | $750.00M | $0.00 | $500.00M | (m) | $91.00M | $4.50B | $-36.00M | $4.00M | $0.00 | (m) | 5.40% | (m) |
| 2015-12-31 | (m) | (m) | $400.00M | $4.46B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $4.90B | $-37.00M | $5.00M | (m) | (m) | (m) | (m) |
| 2015-12-31 | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $0.00 | (m) | 5.20% | (m) |
| 2015-12-31 | (m) | (m) | (m) | (m) | (m) | $400.00M | $0.00 | $750.00M | $0.00 | (m) | $79.00M | (m) | (m) | (m) | (m) | $3.75B | (m) | (m) |
| 2015-09-27 | $0.00 | (m) | $400.00M | $3.23B | (m) | $401.00M | $0.00 | $751.00M | $0.00 | (m) | $79.00M | $3.65B | $-26.00M | $8.00M | $0.00 | (m) | 6.00% | (m) |
| 2015-06-28 | $0.00 | (m) | $400.00M | $3.24B | (m) | $401.00M | $0.00 | $751.00M | $0.00 | (m) | $82.00M | $3.65B | $9.00M | $4.00M | $0.00 | (m) | 6.40% | (m) |
| 2015-03-29 | $0.00 | (m) | $400.00M | $3.24B | (m) | $401.00M | $0.00 | $751.00M | $0.00 | (m) | $68.00M | $3.65B | $9.00M | $2.00M | $0.00 | (m) | 9.70% | (m) |
| 2014-12-31 | $0.00 | (m) | $0.00 | $3.62B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $7.00M | $0.00 | (m) | 9.70% | (m) |
| 2014-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $3.65B | $-29.00M | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | (m) | (m) | (m) | (m) | $0.00 | $401.00M | $1.00M | $751.00M | (m) | $74.00M | (m) | (m) | (m) | (m) | $2.50B | (m) | (m) |
| 2014-09-28 | $0.00 | (m) | (m) | $3.64B | (m) | $0.00 | $401.00M | $1.00M | $750.00M | (m) | $73.00M | $3.65B | $10.00M | $10.00M | $0.00 | (m) | 8.00% | (m) |
| 2014-06-29 | $0.00 | (m) | (m) | $3.64B | (m) | $0.00 | $401.00M | $1.00M | $750.00M | (m) | $61.00M | $3.65B | $10.00M | $12.00M | (m) | (m) | 8.30% | $0.00 |
| 2014-03-30 | (m) | (m) | (m) | $3.64B | (m) | $0.00 | $401.00M | $1.00M | $750.00M | (m) | $67.00M | $3.65B | $10.00M | $16.00M | (m) | (m) | 7.20% | (m) |
| 2013-12-31 | $0.00 | (m) | (m) | $3.64B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $15.00M | $0.00 | (m) | 5.70% | (m) |
| 2013-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $0.00 |
| 2013-12-31 | (m) | (m) | (m) | (m) | (m) | $0.00 | $0.00 | $401.00M | $1.00M | (m) | $69.00M | $3.65B | $10.00M | (m) | (m) | (m) | (m) | (m) |
| 2013-09-29 | $0.00 | (m) | (m) | $3.64B | (m) | $0.00 | $0.00 | $401.00M | $1.00M | (m) | $125.00M | $3.65B | $10.00M | $10.00M | (m) | (m) | 5.40% | $0.00 |
| 2013-06-30 | $0.00 | (m) | (m) | $3.64B | (m) | $0.00 | $0.00 | $400.00M | $0.00 | (m) | (m) | $3.65B | $10.00M | $12.00M | (m) | (m) | 4.60% | $0.00 |
| 2013-03-31 | (m) | (m) | (m) | $3.64B | (m) | $0.00 | $0.00 | $400.00M | $0.00 | (m) | (m) | $3.65B | $10.00M | $6.00M | (m) | $3.25B | 3.00% | (m) |
| 2012-12-31 | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $73.00M | (m) | (m) | 3.70% | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |